SCHEMBL18859550

SCHEMBL18859550

c1ccc(-n2c3ccccc3c3ccc4c5ccccc5n(-c5cccc(-c6nc7c8ccccc8sc7c7ccccc67)c5)c4c32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 3/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ LMNA P02545 2/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TNKS O95271 1/20 0.31
▸ TNKS2 Q9H2K2 1/20 0.31
▸ HTR1A P08908 5/20 0.31
▸ HTR7 P34969 5/20 0.31
▸ PDE1B Q01064 1/20 0.31
▸ PDE3A Q14432 1/20 0.31
▸ PDE11A Q9HCR9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18859541 0.90 ATM (0.38) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL19247682 0.88 ATM (0.34) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL18859536 0.86 ALOX5 (0.36) KDM4EATML3MBTL1TNKSTNKS2
SCHEMBL18859548 0.86 KDM4E (0.35) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL19246745 0.85 L3MBTL1 (0.34) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL18859579 0.85 TNKS (0.33) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL18847258 0.85 MEN1 (0.34) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL24281036 0.84 ATM (0.35) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL25847614 0.84 KMT2A (0.35) KDM4EATML3MBTL1MAPTRXFP1
SCHEMBL19247683 0.84 MAPT (0.31) KDM4EATML3MBTL1MAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA KDM4E 3298/4885ATM 3643/4885L3MBTL1 818/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA KDM4E 3298/4885ATM 3643/4885L3MBTL1 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback